Adma Biologics, Inc.
ADMA
Revenue
139.16M
▲4.94M▲3.68%
3 Months ChangeAssets
624.24M
▲55.56M▲9.77%
3 Months ChangeLiabilities
146.92M
▲9.42M▲6.85%
3 Months ChangeFree Cash Flow
-24.38M
▼-19.81M▼-433.98%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001140361-26-007230
2026-02-25
Form 8-K
ID: 0001140361-26-006781
2026-01-12
Form 8-K
ID: 0001140361-26-000906
2025-11-05
Form 10-Q
ID: 0001140361-25-040578
2025-11-05
Form 8-K
ID: 0001140361-25-040539
2025-08-06
Form 10-Q
ID: 0001140361-25-029177
2025-08-06
Form 8-K
ID: 0001140361-25-029143
2025-06-04
Form 8-K
ID: 0001140361-25-021440
2025-05-07
Form 10-Q
ID: 0001140361-25-017747
2025-05-07
Form 8-K
ID: 0001140361-25-017704